Glucagon-like peptide analogues (GLP-1 analogues) for type 2 diabetes
16 results
1 - 16
Glucagon-like peptide analogues (GLP-1 analogues) for type 2 diabetes 
Dipeptidyl‐peptidase (DPP)‐4 inhibitors and glucagon‐like peptide (GLP)‐1 analogues for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk for the development of type 2 diabetes mellitus- Oral antidiabetic drugs and GLP-1 analogues
- Glucagon-like peptide analogues for type 2 diabetes mellitus: Cochrane systematic review
- Comprehensive treatment and follow-up of type 2 diabetes
- Meglitinide analogues (glinides) for type 2 diabetes mellitus
- Pioglitazone for type 2 diabetes mellitus
- Insulin added on metformin in type 2 diabetes
- Interventions for people with type 2 diabetes mellitus fasting during Ramadan
- Sulphonylurea for type 2 diabetes
- Insulin‐sensitising drugs (metformin, rosiglitazone, pioglitazone, D‐chiro‐inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility
- Metformin for ovulation induction (excluding gonadotrophins) in women with polycystic ovary syndrome